If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
SPECIAL ISSUE<br /> <br /> March 2010<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> THE FORUM FORTHE INDUSTRY EXECUTIVE<br /> <br /> <br /> <br /> <br /> MOLECULE TO MARKET<br /> A Development<br /> Timeline<br /> <br /> <br /> <br /> DRUG DISCOVERY<br /> <br /> PRECLINICAL<br /> <br /> PHASE I<br /> <br /> PHASE II<br /> <br /> PHASE III<br /> <br /> REGISTRATION/LAUNCH<br /> <br /> POSTLAUNCH<br /> <br /> <br />
SPECIAL ISSUEMarch 2010
SPECIAL ISSUEMarch 2010
!S A GLOBAL #2/ KNOWN FOR PROCESS DRIVEN CLINICAL
!S A GLOBAL #2/ KNOWN FOR PROCESS DRIVEN CLINICAL
THE FORUM FOR THE INDUSTRY EXECUTIVEVolume 10
THE FORUM FOR THE INDUSTRY EXECUTIVEVolume 10
SPECIAL ISSUE
SPECIAL ISSUE
532,000 SPREADSHEETSWERE KILLED IN THE MAKING OF
532,000 SPREADSHEETSWERE KILLED IN THE MAKING OF
DIGITAL EDITION — BONUS CONTENTDIGITAL EDI
DIGITAL EDITION — BONUS CONTENTDIGITAL EDI
Challenged by the puzzleof creating channel-neut
Challenged by the puzzleof creating channel-neut
UPFRONTAwardsCHANDLER CHICCONAMED AGENCY
UPFRONTAwardsCHANDLER CHICCONAMED AGENCY
EVERYTHING YOU NEED, NOTHING YOU DON'T
EVERYTHING YOU NEED, NOTHING YOU DON'T
MOLECULE TO MARKETBY TAREN GROMMOLECULE TO
MOLECULE TO MARKETBY TAREN GROMMOLECULE TO
`` DR.TROY MCCALL
`` DR.TROY MCCALL
A
A
needs anis the fast-morphing worldof biopharma.
needs anis the fast-morphing worldof biopharma.
needs anw
needs anw
Copyright © 2010 Quintilesally.Call us. With
Copyright © 2010 Quintilesally.Call us. With
MOLECULE TO MARKET ROBE`RT N`ORRISComplete
MOLECULE TO MARKET ROBE`RT N`ORRISComplete
JAMES DESANTI PharmaVigilantR&D can no longer
JAMES DESANTI PharmaVigilantR&D can no longer
DIGITAL EDITION — BONUS CONTENTBY TAREN GROM
DIGITAL EDITION — BONUS CONTENTBY TAREN GROM
DIGITAL EDITION — BONUS CONTENTMOLECULE TO MAR
DIGITAL EDITION — BONUS CONTENTMOLECULE TO MAR
DIGITAL EDITION — BONUS CONTENTMOLECULE TO MAR
DIGITAL EDITION — BONUS CONTENTMOLECULE TO MAR
DIGITAL EDITION — BONUS CONTENTPRIORIT
DIGITAL EDITION — BONUS CONTENTPRIORIT
Target Identification and Validation
Target Identification and Validation
DO
DO
Drug Discoveryare very important for adva
Drug Discoveryare very important for adva
>[h]Z]VYVaai]Zi^bZ^ci]ZldgaY!
>[h]Z]VYVaai]Zi^bZ^ci]ZldgaY!
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTDrug Discovery
DIGITAL EDITION — BONUS CONTENTDrug Discovery
``Drug Discovery
``Drug Discovery
THE 6TH ANNUAL MEETING OF ISMPPDELIVERING VALUE
THE 6TH ANNUAL MEETING OF ISMPPDELIVERING VALUE
Target Identification and Validation
Target Identification and Validation
Early Development Unforeseen drug toxicitie
Early Development Unforeseen drug toxicitie
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTPr
DIGITAL EDITION — BONUS CONTENTPr
Target Identification and Validation
Target Identification and Validation
Your researchers just
Your researchers just
``Early Development DR. KERRI SCHOE
``Early Development DR. KERRI SCHOE
Early Development ``
Early Development ``
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTEarly Developme
DIGITAL EDITION — BONUS CONTENTEarly Developme
Target Identification and Validation
Target Identification and Validation
serve the integrity of the trial. In Phase III,t
serve the integrity of the trial. In Phase III,t
Early DevelopmentW`e b`elieve that taking the t
Early DevelopmentW`e b`elieve that taking the t
KOL? Patient? Payer?
KOL? Patient? Payer?
Target Identification and Validation
Target Identification and Validation
can limit the potential patient pop-ulation avai
can limit the potential patient pop-ulation avai
Full Development``DR. STEPHEN CUTLER Kendle
Full Development``DR. STEPHEN CUTLER Kendle
(PDLORYHU2QH0LOOLRQ+HDOWK3URIHVVLRQDOV(PDLO
(PDLORYHU2QH0LOOLRQ+HDOWK3URIHVVLRQDOV(PDLO
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTTarget Identifi
DIGITAL EDITION — BONUS CONTENTFull Developmen
DIGITAL EDITION — BONUS CONTENTFull Developmen
Target Identification and Validation
Target Identification and Validation
8IBUTESJWJOHZPVSTBNQMJOH30*3&"$)
8IBUTESJWJOHZPVSTBNQMJOH30*3&"$)
``ANNE TOMALIN i3 CanRegUsing technology that
``ANNE TOMALIN i3 CanRegUsing technology that
Full Developmentin the current treatment of th
Full Developmentin the current treatment of th
FREE WEBSEMINARRegisterNow! www.pharmavoice
FREE WEBSEMINARRegisterNow! www.pharmavoice
DIGITAL EDITI ON — BONUS CONTENTTarget Identif
DIGITAL EDITI ON — BONUS CONTENTTarget Identif
I7L;)&&GZ\^hiZgWn'%&%CWha[j7YY[iiKI7(&'&CWha
I7L;)&&GZ\^hiZgWn'%&%CWha[j7YY[iiKI7(&'&CWha
Target Identification and Validation
Target Identification and Validation
Bronshtein, senior VP, chief compliance offi-cer
Bronshtein, senior VP, chief compliance offi-cer
Full Development``` PATRICK CHASSAIGNE
Full Development``` PATRICK CHASSAIGNE
Frontiers in Drug Development –Not for Physician
Frontiers in Drug Development –Not for Physician
D IGITAL EDITI ON — BONUS CONTENTTarget Identi
D IGITAL EDITI ON — BONUS CONTENTTarget Identi
DIGITAL EDITION — BONUS CONTENT
DIGITAL EDITION — BONUS CONTENT
ExpertsJOHN C. ANDREWS, PH.D. Director of Regu
ExpertsJOHN C. ANDREWS, PH.D. Director of Regu
Expertsences industry. For more informa
Expertsences industry. For more informa
DIGITAL EDITION — BONUS CONTENTPHARMA TRAXSALE
DIGITAL EDITION — BONUS CONTENTPHARMA TRAXSALE
DIGITAL EDITION — BONUS CONTENTPHARMA trax
DIGITAL EDITION — BONUS CONTENTPHARMA trax
DIGITAL EDITION — BONUS CONTENTPHARMA traxQUI
DIGITAL EDITION — BONUS CONTENTPHARMA traxQUI
DIGITAL EDITION — BONUS CONTENTPHARMA trax
DIGITAL EDITION — BONUS CONTENTPHARMA trax
WHAT'S NEWNEW HEALTHCARE-RELATEDPRODUCTS, SERVI
WHAT'S NEWNEW HEALTHCARE-RELATEDPRODUCTS, SERVI
FREE EDUCATIONAL WEBSEMINAR
FREE EDUCATIONAL WEBSEMINAR
WHAT'S newAROUND THE GLOBEU.S.-based pharmace
WHAT'S newAROUND THE GLOBEU.S.-based pharmace
The #1 Event forClinical Development & Operatio
The #1 Event forClinical Development & Operatio
E-MEDIANEW ELECTRONIC ANDWEB-BASED APPLICATI
E-MEDIANEW ELECTRONIC ANDWEB-BASED APPLICATI
Medidata Solutions ProvidesSAFETY REPORT
Medidata Solutions ProvidesSAFETY REPORT
ON THE CALENDAR March March 18-191
ON THE CALENDAR March March 18-191
MORE People are Talking MORE Often on MORE Divers
MORE People are Talking MORE Often on MORE Divers
ON THE CALENDAR March March 15-1615 6t
ON THE CALENDAR March March 15-1615 6t
ON THE CALENDAR March March 17-1817 HI
ON THE CALENDAR March March 17-1817 HI
ON THE CALENDAR March March 22-24 22 S
ON THE CALENDAR March March 22-24 22 S
ON THE CALENDAR MarJch March 31- April
ON THE CALENDAR MarJch March 31- April
ON THE CALENDAR April April 13-14
ON THE CALENDAR April April 13-14
ON THE CALENDAR20Barnett InApril Apr
ON THE CALENDAR20Barnett InApril Apr
ON THE CALENDAR April April 22-23 2
ON THE CALENDAR April April 22-23 2
ON THE CALENDAR26Barnett InApril Apr
ON THE CALENDAR26Barnett InApril Apr
ON THE CALENDAR April April 29-30 2
ON THE CALENDAR April April 29-30 2
ON THE CALENDAR10The HiltMay May 10-
ON THE CALENDAR10The HiltMay May 10-
ON THE CALENDAR May May 13-14 13 P
ON THE CALENDAR May May 13-14 13 P
ON THE CALENDAR May May 19-2019 Aud
ON THE CALENDAR May May 19-2019 Aud
TALENT POOLEXECUTIVE APPOINTMENTSAND PROMOTION
TALENT POOLEXECUTIVE APPOINTMENTSAND PROMOTION
ceuticals. He received an M.D. from New YorkUniv
ceuticals. He received an M.D. from New YorkUniv
TALENT pool CEO of Infinity P
TALENT pool CEO of Infinity P
Dr.Sharon MOOREChiltern Promotes U.S.-Based Exe
Dr.Sharon MOOREChiltern Promotes U.S.-Based Exe
DIGITAL EDITION — BONUS CONTENTTALENT poolPha
DIGITAL EDITION — BONUS CONTENTTALENT poolPha
DIGITAL EDITION — BONUS CONTENTTALENT poolCol
DIGITAL EDITION — BONUS CONTENTTALENT poolCol
The LAST WordAs President of Vaccines,Mr.Swindel
The LAST WordAs President of Vaccines,Mr.Swindel
WWsentation32.motion contact AMM a.
WWsentation32.motion contact AMM a.
DIGITAL EDITION — BONUS CONTENTLAST wordPFI
DIGITAL EDITION — BONUS CONTENTLAST wordPFI
5IFPOMZXBZBDPNQBOZCFDPNFT5)&*/%6453:-&"%&3JTUPB
5IFPOMZXBZBDPNQBOZCFDPNFT5)&*/%6453:-&"%&3JTUPB
The right tools, the right talent.And something
The right tools, the right talent.And something